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Epigenetics describes the inheritable changes in gene ex-
pression without DNA alteration, and its regulation is
involved in stem cell differentiation, development, and
tumorigenesis. This thematic series aims to summarize
recent epigenetic studies in embryonic and adult stem
cells, compare and contrast the epigenetic difference bet-
ween stem cells and cancer cells, and raises provocative
new concepts for cancer treatment.
Tumorigenesis and development are classically regar-
ded as two separate processes. The classical definition of
development describes the embryonic period between
zygote and birth, while tumorigenesis happens after birth.
However, many embryonic pathways are re-activated and/
or dys-regulated in cancer cells. Therefore, studies of stem
cell differentiation and development have provided and
will continue to provide mechanistic insights into tumori-
genesis. Embryonic stem (ES) cells are derived from blas-
tocysts, and they have the ability to develop into the three
germ layers, endoderm, mesoderm, and ectoderm. Be-
cause of the pluripotency, ES cells are a good model sys-
tem to study epigenetics during stem cell differentiation
and early development. After birth, adult stem cells are
the repositories to maintain the homeostasis and to cope
with stresses and injury of adult tissues. From the stand-
point of cancer, ES cell differentiation is relevant to te-
ratomas and testicular tumors. Interestingly, many types
of carcinomas share overlapping transcriptomes with ES
cells, suggesting that part of the embryonic transcription
program is re-activated in tumors, possibly via epigenetic
regulation [1,2]. Accumulating evidence indicates that
many types of tumors consist of stem cell-like cells, dub-
bed cancer stem cells (CSCs) or cancer initiating cells
(CICs). CSCs or CICs may come from transformed adult
stem cells or terminally differentiated cells that are re-
programmed. To fully understand the epigenetic altera-
tions in cancer stem cells, it is important to have aCorrespondence: huangj3@mail.nih.gov
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reproduction in any medium, provided the orglobal picture of the epigenetic landscapes in normal
adult stem cells.
Compared with adult stem cells and somatic cells, ES
cells have a distinct epigenetic landscape [3]. How that
landscape affects ES cell differentiation and pluripotency
has attracted a lot of attention. Gu et al., review the roles
of one of the most well studied histone methylations,
histone H3 lysine 4 methylation (H3K4me), in ES cells
as well as in adult stem cells [4]. Because many of the
enzymes that regulate H3K4me are also involved in
tumorigenesis, this review may advance our understan-
ding of H3K4me-modifying enzymes in cancer.
Myogenesis is the process of the development of heart
and skeletal muscles. It is one of the most well docu-
mented differentiation processes of ES cells. Abnormal
myogenesis may be also related to rhabdomyosar-
comagenesis. Chen and Li summarize the epigenetic
events and signaling pathways that regulate myoge-
nesis from ES cells [5]. They concentrate on histone
acetylation and small molecule compounds that can
induce myogenesis.
Certain types of tumors have CSCs or CICs, which
have similar features as adult stem cells. Tarayrah et al.,
systematically review the epigenetic regulation of several
adult stem cells, e.g. germline stem cells (GSCs), intes-
tinal stem cells (ISCs), and hair follicle stem cells [6]. In
addition, abnormal epigenetic regulations in cancer cells,
such as DNA methylation, histone modifications, and
chromatin remodeling, are summarized. Because epige-
netic changes are reversible, they represent attractive in-
tervention nodes for cancer treatment.
The tumor suppressor p53 plays many important
roles in regulating stem cell differentiation and sup-
pressing tumors. Shin et al., highlight the recent stu-
dies of p53 in ES cells, and describe how these studies
provide mechanistic insights into the relationship bet-
ween the developmental role and tumor suppressive
function of p53 [7].his is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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